Cargando…

P536: A FIRST-IN-HUMAN PHASE 1 STUDY OF IO-202 (ANTI-LILRB4 MAB) IN ACUTE MYELOID LEUKEMIA (AML) WITH MONOCYTIC DIFFERENTIATION AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS

Detalles Bibliográficos
Autores principales: Dinardo, Courtney, Pollyea, Daniel, Aribi, Ahmed, Jonas, Brian, Jeyakumar, Deepa, Roboz, Gail, Liu, Hongtao, Dunavin, Neil, Blum, William, Zhang, Alec, Tabata, Yasuhiro, Valencia, Donna, Huang, Tao, Hong, Kyu, Xiang, Hong, Liao, Charlene, Woodard, Paul, Madanat, Yazan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428933/
http://dx.doi.org/10.1097/01.HS9.0000969052.60533.5a
_version_ 1785090589368254464
author Dinardo, Courtney
Pollyea, Daniel
Aribi, Ahmed
Jonas, Brian
Jeyakumar, Deepa
Roboz, Gail
Liu, Hongtao
Dunavin, Neil
Blum, William
Zhang, Alec
Tabata, Yasuhiro
Valencia, Donna
Huang, Tao
Hong, Kyu
Xiang, Hong
Liao, Charlene
Woodard, Paul
Madanat, Yazan
author_facet Dinardo, Courtney
Pollyea, Daniel
Aribi, Ahmed
Jonas, Brian
Jeyakumar, Deepa
Roboz, Gail
Liu, Hongtao
Dunavin, Neil
Blum, William
Zhang, Alec
Tabata, Yasuhiro
Valencia, Donna
Huang, Tao
Hong, Kyu
Xiang, Hong
Liao, Charlene
Woodard, Paul
Madanat, Yazan
author_sort Dinardo, Courtney
collection PubMed
description
format Online
Article
Text
id pubmed-10428933
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104289332023-08-17 P536: A FIRST-IN-HUMAN PHASE 1 STUDY OF IO-202 (ANTI-LILRB4 MAB) IN ACUTE MYELOID LEUKEMIA (AML) WITH MONOCYTIC DIFFERENTIATION AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS Dinardo, Courtney Pollyea, Daniel Aribi, Ahmed Jonas, Brian Jeyakumar, Deepa Roboz, Gail Liu, Hongtao Dunavin, Neil Blum, William Zhang, Alec Tabata, Yasuhiro Valencia, Donna Huang, Tao Hong, Kyu Xiang, Hong Liao, Charlene Woodard, Paul Madanat, Yazan Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428933/ http://dx.doi.org/10.1097/01.HS9.0000969052.60533.5a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Dinardo, Courtney
Pollyea, Daniel
Aribi, Ahmed
Jonas, Brian
Jeyakumar, Deepa
Roboz, Gail
Liu, Hongtao
Dunavin, Neil
Blum, William
Zhang, Alec
Tabata, Yasuhiro
Valencia, Donna
Huang, Tao
Hong, Kyu
Xiang, Hong
Liao, Charlene
Woodard, Paul
Madanat, Yazan
P536: A FIRST-IN-HUMAN PHASE 1 STUDY OF IO-202 (ANTI-LILRB4 MAB) IN ACUTE MYELOID LEUKEMIA (AML) WITH MONOCYTIC DIFFERENTIATION AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS
title P536: A FIRST-IN-HUMAN PHASE 1 STUDY OF IO-202 (ANTI-LILRB4 MAB) IN ACUTE MYELOID LEUKEMIA (AML) WITH MONOCYTIC DIFFERENTIATION AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS
title_full P536: A FIRST-IN-HUMAN PHASE 1 STUDY OF IO-202 (ANTI-LILRB4 MAB) IN ACUTE MYELOID LEUKEMIA (AML) WITH MONOCYTIC DIFFERENTIATION AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS
title_fullStr P536: A FIRST-IN-HUMAN PHASE 1 STUDY OF IO-202 (ANTI-LILRB4 MAB) IN ACUTE MYELOID LEUKEMIA (AML) WITH MONOCYTIC DIFFERENTIATION AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS
title_full_unstemmed P536: A FIRST-IN-HUMAN PHASE 1 STUDY OF IO-202 (ANTI-LILRB4 MAB) IN ACUTE MYELOID LEUKEMIA (AML) WITH MONOCYTIC DIFFERENTIATION AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS
title_short P536: A FIRST-IN-HUMAN PHASE 1 STUDY OF IO-202 (ANTI-LILRB4 MAB) IN ACUTE MYELOID LEUKEMIA (AML) WITH MONOCYTIC DIFFERENTIATION AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS
title_sort p536: a first-in-human phase 1 study of io-202 (anti-lilrb4 mab) in acute myeloid leukemia (aml) with monocytic differentiation and chronic myelomonocytic leukemia (cmml) patients
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428933/
http://dx.doi.org/10.1097/01.HS9.0000969052.60533.5a
work_keys_str_mv AT dinardocourtney p536afirstinhumanphase1studyofio202antililrb4mabinacutemyeloidleukemiaamlwithmonocyticdifferentiationandchronicmyelomonocyticleukemiacmmlpatients
AT pollyeadaniel p536afirstinhumanphase1studyofio202antililrb4mabinacutemyeloidleukemiaamlwithmonocyticdifferentiationandchronicmyelomonocyticleukemiacmmlpatients
AT aribiahmed p536afirstinhumanphase1studyofio202antililrb4mabinacutemyeloidleukemiaamlwithmonocyticdifferentiationandchronicmyelomonocyticleukemiacmmlpatients
AT jonasbrian p536afirstinhumanphase1studyofio202antililrb4mabinacutemyeloidleukemiaamlwithmonocyticdifferentiationandchronicmyelomonocyticleukemiacmmlpatients
AT jeyakumardeepa p536afirstinhumanphase1studyofio202antililrb4mabinacutemyeloidleukemiaamlwithmonocyticdifferentiationandchronicmyelomonocyticleukemiacmmlpatients
AT robozgail p536afirstinhumanphase1studyofio202antililrb4mabinacutemyeloidleukemiaamlwithmonocyticdifferentiationandchronicmyelomonocyticleukemiacmmlpatients
AT liuhongtao p536afirstinhumanphase1studyofio202antililrb4mabinacutemyeloidleukemiaamlwithmonocyticdifferentiationandchronicmyelomonocyticleukemiacmmlpatients
AT dunavinneil p536afirstinhumanphase1studyofio202antililrb4mabinacutemyeloidleukemiaamlwithmonocyticdifferentiationandchronicmyelomonocyticleukemiacmmlpatients
AT blumwilliam p536afirstinhumanphase1studyofio202antililrb4mabinacutemyeloidleukemiaamlwithmonocyticdifferentiationandchronicmyelomonocyticleukemiacmmlpatients
AT zhangalec p536afirstinhumanphase1studyofio202antililrb4mabinacutemyeloidleukemiaamlwithmonocyticdifferentiationandchronicmyelomonocyticleukemiacmmlpatients
AT tabatayasuhiro p536afirstinhumanphase1studyofio202antililrb4mabinacutemyeloidleukemiaamlwithmonocyticdifferentiationandchronicmyelomonocyticleukemiacmmlpatients
AT valenciadonna p536afirstinhumanphase1studyofio202antililrb4mabinacutemyeloidleukemiaamlwithmonocyticdifferentiationandchronicmyelomonocyticleukemiacmmlpatients
AT huangtao p536afirstinhumanphase1studyofio202antililrb4mabinacutemyeloidleukemiaamlwithmonocyticdifferentiationandchronicmyelomonocyticleukemiacmmlpatients
AT hongkyu p536afirstinhumanphase1studyofio202antililrb4mabinacutemyeloidleukemiaamlwithmonocyticdifferentiationandchronicmyelomonocyticleukemiacmmlpatients
AT xianghong p536afirstinhumanphase1studyofio202antililrb4mabinacutemyeloidleukemiaamlwithmonocyticdifferentiationandchronicmyelomonocyticleukemiacmmlpatients
AT liaocharlene p536afirstinhumanphase1studyofio202antililrb4mabinacutemyeloidleukemiaamlwithmonocyticdifferentiationandchronicmyelomonocyticleukemiacmmlpatients
AT woodardpaul p536afirstinhumanphase1studyofio202antililrb4mabinacutemyeloidleukemiaamlwithmonocyticdifferentiationandchronicmyelomonocyticleukemiacmmlpatients
AT madanatyazan p536afirstinhumanphase1studyofio202antililrb4mabinacutemyeloidleukemiaamlwithmonocyticdifferentiationandchronicmyelomonocyticleukemiacmmlpatients